Table 2 Patients’ outcomes in the overall population and in septic and non-septic subgroups
Analysis cohort | Sepsis | Non-sepsis | p-value | |
|---|---|---|---|---|
Patients | 433 | 181 | 252 | |
AKI at ICU admission | 26 (6.0) | 14 (7.7) | 12 (4.8) | 0.001* |
Stage 1 | 14 (3.2) | 8 (4.4) | 6 (2.4) | |
Stage 2 | 5 (1.1) | 2 (1.1) | 3 (1.2) | |
Stage 3 | 7 (1.6) | 4 (2.2) | 3 (1.2) | |
AKI within 24 h | 149 (34.4) | 82 (45.3) | 67 (26.6) | < 0.001* |
Stage 1 | 46 (10.6) | 25 (13.8) | 21 (8.3) | |
Stage 2 | 38 (8.8) | 19 (10.5) | 19 (7.5) | |
Stage 3 | 65 (15.0) | 38 (21.0) | 27 (10.7) | |
AKI within 48 h | 168 (38.8) | 93 (51.4) | 75 (29.8) | < 0.001* |
Stage 1 | 55 (12.7) | 31 (17.1) | 24 (9.5) | |
Stage 2 | 44 (10.2) | 22 (12.2) | 22 (8.7) | |
Stage 3 | 69 (15.9) | 40 (22.1) | 29 (11.5) | |
RRT need | 33 (7.6) | 18 (9.9) | 15 (6.0) | |
AKD at 7 days | 47 (10.8) | 26 (14.4) | 21 (8.3) | < 0.01* |
Stage 0 | 15 (3.5) | 10 (5.5) | 5 (2.0) | |
Stage 1 | 9 (2.1) | 5 (2.8) | 4 (1.6) | |
Stage 2 | 7 (1.6) | 4 (2.2) | 3 (1.2) | |
Stage 3 | 16 (3.7) | 7 (3.9) | 9 (3.6) | |
RRT need | 14 (3.2) | 7 (3.9) | 7 (2.8) | |
7 days mortality | 65 (15.0) | 37 (20.4) | 28 (11.1) | < 0.01* |
ICU mortality | 100 (23.1) | 50 (27.6) | 50 (19.8) | 0.57 |
Days in ICU | 4 (2-11) | 4 (2–10) | 4 (2–11) | 0.77 |
Hospital mortality | 128 (29.6) | 64 (35.4) | 64 (25.4) | 0.37 |
Days in hospital | 15 (7–31) | 13 (6–30) | 15 (7–31) | 0.27 |